ACASTI - ACA-CAP-001 Hypertriglyceridemia

Investigator: Mahendra Jain, MD

Study Coordinator: Bela Jain

Status: Enrolling Number: NCT03398005

Phone: 281.485.3434

Protocol Number: Pro00019216


To determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting triglyceride levels in patients with fasting levels ≥500 mg/dL and ≤1500 mg/dL after 12 weeks of treatment.
More to Explore
Live Chat Available